{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:11:53Z","timestamp":1785773513626,"version":"3.56.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["NIH-AG12161"],"award-info":[{"award-number":["NIH-AG12161"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIFA-USDA","award":["NJAES-0153866"],"award-info":[{"award-number":["NJAES-0153866"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s40618-021-01633-1","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T17:03:11Z","timestamp":1626714191000},"page":"301-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Total and free vitamin D metabolites in patients with primary hyperparathyroidism"],"prefix":"10.1007","volume":"45","author":[{"given":"L.","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Shapses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"issue":"11","key":"1633_CR1","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1210\/jc.2018-01225","volume":"103","author":"JP Bilezikian","year":"2018","unstructured":"Bilezikian JP (2018) Primary hyperparathyroidism. J Clin Endocrinol Metab 103(11):3993\u20134004. https:\/\/doi.org\/10.1210\/jc.2018-01225","journal-title":"J Clin Endocrinol Metab"},{"key":"1633_CR2","volume-title":"Dietary reference intakes for calcium and vitamin D","author":"IOM (Institute of Medicine)","year":"2011","unstructured":"IOM (Institute of Medicine) (2011) Dietary reference intakes for calcium and vitamin D. National Academies Press, Washington"},{"issue":"5","key":"1633_CR3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1365-2265.2005.02371.x","volume":"63","author":"B Moosgaard","year":"2005","unstructured":"Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L (2005) Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol 63(5):506\u2013513. https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02371.x","journal-title":"Clin Endocrinol"},{"issue":"1","key":"1633_CR4","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1038\/s41467-020-19793-8","volume":"11","author":"RL Thomas","year":"2020","unstructured":"Thomas RL, Jiang L, Adams JS, Xu ZZ, Shen J, Janssen S et al (2020) Vitamin D metabolites and the gut microbiome in older men. Nat Commun 11(1):5997. https:\/\/doi.org\/10.1038\/s41467-020-19793-8","journal-title":"Nat Commun"},{"key":"1633_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.bbacli.2015.03.004","volume":"3","author":"M Pasquali","year":"2015","unstructured":"Pasquali M, Tartaglione L, Rotondi S, Muci ML, Mandanici G, Farcomeni A et al (2015) Calcitriol\/calcifediol ratio: an indicator of vitamin D hydroxylation efficiency? BBA Clin 3:251\u2013256. https:\/\/doi.org\/10.1016\/j.bbacli.2015.03.004","journal-title":"BBA Clin"},{"issue":"1","key":"1633_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1042\/bj1640083","volume":"164","author":"KW Colston","year":"1977","unstructured":"Colston KW, Evans IM, Spelsberg TC, MacIntyre I (1977) Feedback regulation of vitamin D metabolism by 1,25-dihydroxycholecalciferol. Biochem J 164(1):83\u201389. https:\/\/doi.org\/10.1042\/bj1640083","journal-title":"Biochem J"},{"issue":"110","key":"1633_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/newbio241163a0","volume":"241","author":"DR Fraser","year":"1973","unstructured":"Fraser DR, Kodicek E (1973) Regulation of 25-hydroxycholecalciferol-1-hydroxylase activity in kidney by parathyroid hormone. Nat New Biol 241(110):163\u2013166. https:\/\/doi.org\/10.1038\/newbio241163a0","journal-title":"Nat New Biol"},{"issue":"5","key":"1633_CR8","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1172\/jci108878","volume":"160","author":"SJ Birge","year":"1977","unstructured":"Birge SJ, Miller R (1977) The role of phosphate in the action of vitamin D on the intestine. J Clin Investig 160(5):980\u2013988. https:\/\/doi.org\/10.1172\/jci108878","journal-title":"J Clin Investig"},{"issue":"5","key":"1633_CR9","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1210\/jcem-67-5-876","volume":"67","author":"TO Pitts","year":"1988","unstructured":"Pitts TO, Piraino BH, Mitro R, Chen TC, Segre GV, Greenberg A et al (1988) Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. J Clin Endocrinol Metab 67(5):876\u2013881. https:\/\/doi.org\/10.1210\/jcem-67-5-876","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1633_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1365-2265.2006.02680.x","volume":"66","author":"B Moosgaard","year":"2007","unstructured":"Moosgaard B, Vestergaard P, Heickendorff L, Mosekilde L (2007) Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function. Clin Endocrinol 66(1):35\u201342. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02680.x","journal-title":"Clin Endocrinol"},{"issue":"5","key":"1633_CR11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.4158\/ep161604.Ra","volume":"23","author":"NK Jassil","year":"2017","unstructured":"Jassil NK, Sharma A, Bikle D, Wang X (2017) Vitamin D binding protein and 25-hydroxyvitamin D levels: emerging clinical applications. Endocr Pract 23(5):605\u2013613. https:\/\/doi.org\/10.4158\/ep161604.Ra","journal-title":"Endocr Pract"},{"issue":"1","key":"1633_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1042\/cs0760081","volume":"76","author":"BC Lalor","year":"1989","unstructured":"Lalor BC, Mawer EB, Davies M, Lumb GA, Hunt L, Adams PH (1989) Determinants of the serum concentration of 1,25-dihydroxyvitamin D in primary hyperparathyroidism. Clinical Sci 76(1):81\u201386. https:\/\/doi.org\/10.1042\/cs0760081 (London, England: 1979)","journal-title":"Clinical Sci"},{"issue":"2","key":"1633_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4158\/ep-2019-0325","volume":"26","author":"X Wang","year":"2020","unstructured":"Wang X, Meng L, Su C, Shapses SA (2020) Low free (but not total) 25-hydroxyvitamin D levels in subjects with normocalcemic hyperparathyroidism. Endocr Pract 26(2):174\u2013178. https:\/\/doi.org\/10.4158\/ep-2019-0325","journal-title":"Endocr Pract"},{"issue":"1","key":"1633_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00198-016-3735-z","volume":"28","author":"LC Pop","year":"2017","unstructured":"Pop LC, Sukumar D, Schneider SH, Schlussel Y, Stahl T, Gordon C et al (2017) Three doses of vitamin D, bone mineral density, and geometry in older women during modest weight control in a 1-year randomized controlled trial. Osteoporos Int 28(1):377\u2013388. https:\/\/doi.org\/10.1007\/s00198-016-3735-z","journal-title":"Osteoporos Int"},{"issue":"4","key":"1633_CR15","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1210\/jcem-63-4-954","volume":"63","author":"DD Bikle","year":"1986","unstructured":"Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG (1986) Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab 63(4):954\u2013959. https:\/\/doi.org\/10.1210\/jcem-63-4-954","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1633_CR16","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","volume":"84","author":"A Vermeulen","year":"1999","unstructured":"Vermeulen A, Verdonck L, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84(10):3666\u20133672. https:\/\/doi.org\/10.1210\/jcem.84.10.6079","journal-title":"J Clin Endocrinol Metab"},{"key":"1633_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2020.105616","volume":"199","author":"L Meng","year":"2020","unstructured":"Meng L, Su C, Shapses SA, Al-Dayyeni A, He Y, Wang X (2020) Lower total 25-hydroxyvitamin D but no difference in calculated or measured free 25-hydroxyvitamin D serum levels in patients with primary hyperparathyroidism. J Steroid Biochem Mol Biol 199:105616. https:\/\/doi.org\/10.1016\/j.jsbmb.2020.105616","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"1633_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s12020-016-0974-x","volume":"55","author":"C Battista","year":"2017","unstructured":"Battista C, Guarnieri V, Carnevale V, Baorda F, Pileri M, Garrubba M et al (2017) Vitamin D status in primary hyperparathyroidism: effect of genetic background. Endocrine 55(1):266\u2013272. https:\/\/doi.org\/10.1007\/s12020-016-0974-x","journal-title":"Endocrine"},{"key":"1633_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fendo.2019.00171","volume":"10","author":"X Wang","year":"2019","unstructured":"Wang X, Sheng Z, Meng L, Su C, Trooskin S, Shapses SA (2019) 25-hydroxyvitamin D and vitamin D binding protein levels in patients with primary hyperparathyroidism before and after parathyroidectomy. Front Endocrinol 10:171. https:\/\/doi.org\/10.3389\/fendo.2019.00171","journal-title":"Front Endocrinol"},{"key":"1633_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3389\/fendo.2019.00317","volume":"10","author":"DD Bikle","year":"2019","unstructured":"Bikle DD, Schwartz J (2019) Vitamin D binding protein, total and free vitamin D levels in different physiological and pathophysiological conditions. Front Endocrinol 10:317. https:\/\/doi.org\/10.3389\/fendo.2019.00317","journal-title":"Front Endocrinol"},{"issue":"6","key":"1633_CR21","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1530\/eje.0.1480597","volume":"148","author":"H Yamashita","year":"2003","unstructured":"Yamashita H, Noguchi S, Uchino S, Watanabe S, Murakami T, Ogawa T et al (2003) Influence of renal function on clinico-pathological features of primary hyperparathyroidism. Eur J Endocrinol 148(6):597\u2013602. https:\/\/doi.org\/10.1530\/eje.0.1480597","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"1633_CR22","first-page":"186","volume":"55","author":"L Brandi","year":"2008","unstructured":"Brandi L (2008) 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol\u2013an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Danish Med Bull 55(4):186\u2013210","journal-title":"Danish Med Bull"},{"issue":"4","key":"1633_CR23","first-page":"203","volume":"22","author":"A Fr\u00f8lich","year":"1996","unstructured":"Fr\u00f8lich A, Storm T, Thode J (1996) Does the plasma concentration of 25-hydroxyvitamin D determine the level of 1,25-dihydroxyvitamin D in primary hyperparathyroidism? Miner Electrolyte Metab 22(4):203\u2013206","journal-title":"Miner Electrolyte Metab"},{"issue":"3","key":"1633_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0169-6009(89)90006-8","volume":"5","author":"L Mosekilde","year":"1989","unstructured":"Mosekilde L, Charles P, Lindegreen P (1989) Determinants for serum 1,25-dihydroxycholecalciferol in primary hyperparathyroidism. Bone Miner 5(3):279\u2013290. https:\/\/doi.org\/10.1016\/0169-6009(89)90006-8","journal-title":"Bone Miner"},{"issue":"4","key":"1633_CR25","first-page":"210","volume":"16","author":"A Fr\u00f8lich","year":"1990","unstructured":"Fr\u00f8lich A, Nielsen BF, Transb\u00f8l I (1990) Respective roles of 25 hydroxy-vitamin D, PTH, phosphate and renal function for the 1-alpha-hydroxylase activity in primary hyperparathyroidism. Miner Electrolyte Metab 16(4):210\u2013215","journal-title":"Miner Electrolyte Metab"},{"issue":"4","key":"1633_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/bf02555137","volume":"43","author":"P Nygren","year":"1988","unstructured":"Nygren P, Larsson R, Johansson H, Ljunghall S, Rastad J, Akerstr\u00f6m G (1988) 1,25(OH)2D3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells. Calcif Tissue Int 43(4):213\u2013218. https:\/\/doi.org\/10.1007\/bf02555137","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"1633_CR27","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1073\/pnas.82.12.4270","volume":"82","author":"J Silver","year":"1985","unstructured":"Silver J, Russell J, Sherwood LM (1985) Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci USA 82(12):4270\u20134273. https:\/\/doi.org\/10.1073\/pnas.82.12.4270","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"1633_CR28","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.ekir.2019.08.014","volume":"4","author":"N Bansal","year":"2019","unstructured":"Bansal N, Katz R, Appel L, Denburg M, Feldman H, Go AS et al (2019) Vitamin D metabolic ratio and risks of death and CKD progression. Kidney Int Rep 4(11):1598\u20131607. https:\/\/doi.org\/10.1016\/j.ekir.2019.08.014","journal-title":"Kidney Int Rep"},{"issue":"3","key":"1633_CR29","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1210\/jc.2004-1891","volume":"90","author":"MJ Bolland","year":"2005","unstructured":"Bolland MJ, Grey AB, Gamble GD, Reid IR (2005) Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J Clin Endocrinol Metab 90(3):1525\u20131530. https:\/\/doi.org\/10.1210\/jc.2004-1891","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1633_CR30","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1210\/jc.2005-0216","volume":"90","author":"MB Snijder","year":"2005","unstructured":"Snijder MB, van Dam RM, Visser M, Deeg DJ, Dekker JM, Bouter LM et al (2005) Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 90(7):4119\u20134123. https:\/\/doi.org\/10.1210\/jc.2005-0216","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1633_CR31","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1210\/jc.2003-031398","volume":"89","author":"SJ Parikh","year":"2004","unstructured":"Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J et al (2004) The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 89(3):1196\u20131199. https:\/\/doi.org\/10.1210\/jc.2003-031398","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1633_CR32","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/ajcn\/47.4.694","volume":"47","author":"SL Ash","year":"1988","unstructured":"Ash SL, Goldin BR (1988) Effects of age and estrogen on renal vitamin D metabolism in the female rat. Am J Clin Nutr 47(4):694\u2013699. https:\/\/doi.org\/10.1093\/ajcn\/47.4.694","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"1633_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00404-020-05567-6","volume":"302","author":"F Saki","year":"2020","unstructured":"Saki F, Sadeghian F, Kasaee SR, Koohpeyma F, Ranjbar Omrani GH (2020) Effect of prolactin and estrogen on the serum level of 1,25-dihydroxy vitamin D and FGF23 in female rats. Arch Gynecol Obstet 302(1):265\u2013271. https:\/\/doi.org\/10.1007\/s00404-020-05567-6","journal-title":"Arch Gynecol Obstet"},{"issue":"8","key":"1633_CR34","doi-asserted-by":"publisher","first-page":"936","DOI":"10.4158\/ep15623.Or","volume":"21","author":"LC Pop","year":"2015","unstructured":"Pop LC, Shapses SA, Chang B, Sun W, Wang X (2015) VItamin D-binding protein in healthy pre- and postmenopausal women: relationship with estradiol concentrations. Endocr Pract 21(8):936\u2013942. https:\/\/doi.org\/10.4158\/ep15623.Or","journal-title":"Endocr Pract"},{"issue":"6","key":"1633_CR35","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/nep.12638","volume":"21","author":"A Aggarwal","year":"2016","unstructured":"Aggarwal A, Yadav AK, Ramachandran R, Kumar V, Kumar V, Sachdeva N et al (2016) Bioavailable vitamin D levels are reduced and correlate with bone mineral density and markers of mineral metabolism in adults with nephrotic syndrome. Nephrology (Carlton) 21(6):483\u2013489. https:\/\/doi.org\/10.1111\/nep.12638","journal-title":"Nephrology (Carlton)"},{"issue":"8029","key":"1633_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/s0140-6736(77)90118-0","volume":"2","author":"H Schmidt-Gayk","year":"1977","unstructured":"Schmidt-Gayk H, Grawunder C, Tsch\u00f6pe W, Schmitt W, Ritz E, Pietsch V et al (1977) 25-hydroxy-vitamin-D in nephrotic syndrome. Lancet (London, England) 2(8029):105\u2013108. https:\/\/doi.org\/10.1016\/s0140-6736(77)90118-0","journal-title":"Lancet (London, England)"},{"issue":"2","key":"1633_CR37","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s12020-020-02427-w","volume":"70","author":"C Su","year":"2020","unstructured":"Su C, Meng L, Trooskin SZ, Shapses SA, He Y, Al-Dayyeni A et al (2020) Serum Klotho levels in primary hyperparathyroidism patients before and after parathyroidectomy. Endocrine 70(2):421\u2013425. https:\/\/doi.org\/10.1007\/s12020-020-02427-w","journal-title":"Endocrine"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01633-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-021-01633-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01633-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T10:21:31Z","timestamp":1642846891000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-021-01633-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1633"],"URL":"https:\/\/doi.org\/10.1007\/s40618-021-01633-1","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,19]]},"assertion":[{"value":"21 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Lingqiong Meng, Chi Su, Sue A Shapses, and Xiangbing Wang declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Rutgers-Robert Wood Johnson Medical School and Rutgers University IRB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study. The participants signed informed consent regarding publishing their data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}